SHL Telemedicine Ltd. (NASDAQ: SHLT) Stock Competitors & Peer Comparison

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, VEEV has a market cap of 30.7B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while VEEV trades at $189.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas VEEV's P/E ratio is 22.71. In terms of profitability, SHLT's ROE is -0.50%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, SHLT is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check VEEV's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while GEHC trades at $62.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas GEHC's P/E ratio is 13.61. In terms of profitability, SHLT's ROE is -0.50%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SHLT is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check GEHC's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SHLT is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check GEHCV's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, BTSGU has a market cap of 14.4B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while BTSGU trades at $239.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas BTSGU's P/E ratio is 216.59. In terms of profitability, SHLT's ROE is -0.50%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, SHLT is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check BTSGU's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, BTSG has a market cap of 14.2B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while BTSG trades at $72.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas BTSG's P/E ratio is 58.52. In terms of profitability, SHLT's ROE is -0.50%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, SHLT is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check BTSG's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SHLT's ROE is -0.50%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SHLT is less volatile compared to SGFY. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SGFY's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, TEM has a market cap of 8.5B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while TEM trades at $48.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas TEM's P/E ratio is -97.96. In terms of profitability, SHLT's ROE is -0.50%, compared to TEM's ROE of -0.70%. Regarding short-term risk, SHLT is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check TEM's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while HQY trades at $97.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas HQY's P/E ratio is 22.84. In terms of profitability, SHLT's ROE is -0.50%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SHLT is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check HQY's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, HNGE has a market cap of 6.5B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while HNGE trades at $84.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas HNGE's P/E ratio is 43.22. In terms of profitability, SHLT's ROE is -0.50%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, SHLT is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check HNGE's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas RCM's P/E ratio is -102.21. In terms of profitability, SHLT's ROE is -0.50%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SHLT is similarly volatile compared to RCM. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check RCM's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, TXG has a market cap of 6B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while TXG trades at $47.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas TXG's P/E ratio is -277.65. In terms of profitability, SHLT's ROE is -0.50%, compared to TXG's ROE of -0.03%. Regarding short-term risk, SHLT is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check TXG's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, DOCS has a market cap of 3.9B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while DOCS trades at $21.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas DOCS's P/E ratio is 13.79. In terms of profitability, SHLT's ROE is -0.50%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, SHLT is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check DOCS's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SHLT's ROE is -0.50%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SHLT is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check ONEM's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, PRVA has a market cap of 3.3B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while PRVA trades at $26.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas PRVA's P/E ratio is 164.44. In terms of profitability, SHLT's ROE is -0.50%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, SHLT is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check PRVA's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while PGNY trades at $32.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas PGNY's P/E ratio is 23.53. In terms of profitability, SHLT's ROE is -0.50%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, SHLT is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check PGNY's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while HTFL trades at $25.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas HTFL's P/E ratio is -12.66. In terms of profitability, SHLT's ROE is -0.50%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SHLT is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check HTFL's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while WGS trades at $61.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas WGS's P/E ratio is 72.53. In terms of profitability, SHLT's ROE is -0.50%, compared to WGS's ROE of -0.28%. Regarding short-term risk, SHLT is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check WGS's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, TDOC has a market cap of 1.8B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while TDOC trades at $9.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas TDOC's P/E ratio is -10.79. In terms of profitability, SHLT's ROE is -0.50%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, SHLT is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check TDOC's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SHLT's ROE is -0.50%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SHLT is less volatile compared to NXGN. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check NXGN's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SHLT's ROE is -0.50%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SHLT is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check AGTI's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while OMDA trades at $22.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas OMDA's P/E ratio is 328.43. In terms of profitability, SHLT's ROE is -0.50%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, SHLT is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check OMDA's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CERT trades at $6.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CERT's P/E ratio is 17.56. In terms of profitability, SHLT's ROE is -0.50%, compared to CERT's ROE of -0.01%. Regarding short-term risk, SHLT is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CERT's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while GDRX trades at $3.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas GDRX's P/E ratio is 9.15. In terms of profitability, SHLT's ROE is -0.50%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SHLT is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check GDRX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SHLT is similarly volatile compared to CCLDO. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check CCLDO's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, HSTM has a market cap of 813.4M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while HSTM trades at $27.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas HSTM's P/E ratio is 36.63. In terms of profitability, SHLT's ROE is -0.50%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SHLT is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check HSTM's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, EVH has a market cap of 656.9M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while EVH trades at $5.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas EVH's P/E ratio is 584.00. In terms of profitability, SHLT's ROE is -0.50%, compared to EVH's ROE of -0.78%. Regarding short-term risk, SHLT is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check EVH's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, PHR has a market cap of 654.6M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while PHR trades at $10.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas PHR's P/E ratio is 37.82. In terms of profitability, SHLT's ROE is -0.50%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SHLT is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check PHR's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, SHLT is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check MPLN-WT's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SHLT's ROE is -0.50%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SHLT is similarly volatile compared to ACCD. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check ACCD's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SHLT's ROE is -0.50%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SHLT is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SHCR's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while WGSWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas WGSWW's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, SHLT is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check WGSWW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CTEV has a market cap of 488.4M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CTEV trades at $28.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CTEV's P/E ratio is -2.20. In terms of profitability, SHLT's ROE is -0.50%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, SHLT is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CTEV's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, NRC has a market cap of 484.1M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while NRC trades at $21.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas NRC's P/E ratio is 26.20. In terms of profitability, SHLT's ROE is -0.50%, compared to NRC's ROE of +0.57%. Regarding short-term risk, SHLT is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check NRC's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SOPH has a market cap of 446.8M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SOPH trades at $6.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SOPH's P/E ratio is -12.50. In terms of profitability, SHLT's ROE is -0.50%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, SHLT is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SOPH's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SHLT's ROE is -0.50%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SHLT is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SLGC's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SHLT's ROE is -0.50%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SHLT is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SLGCW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SHLT's ROE is -0.50%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SHLT is less volatile compared to TBRG. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check TBRG's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SHLT's ROE is -0.50%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, SHLT is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check MPLN's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SLP trades at $18.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SLP's P/E ratio is 20.72. In terms of profitability, SHLT's ROE is -0.50%, compared to SLP's ROE of +0.06%. Regarding short-term risk, SHLT is less volatile compared to SLP. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SLP's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SHLT's ROE is -0.50%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SHLT is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check TRHC's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SMFR's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, SHLT is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SMFR's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SY has a market cap of 240.1M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SY trades at $1.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SY's P/E ratio is -5.55. In terms of profitability, SHLT's ROE is -0.50%, compared to SY's ROE of -0.16%. Regarding short-term risk, SHLT is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SY's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SPOK has a market cap of 222.7M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SPOK trades at $10.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SPOK's P/E ratio is 17.77. In terms of profitability, SHLT's ROE is -0.50%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, SHLT is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SPOK's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, AMWL has a market cap of 209M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while AMWL trades at $12.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas AMWL's P/E ratio is -2.41. In terms of profitability, SHLT's ROE is -0.50%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, SHLT is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check AMWL's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, HCAT has a market cap of 159.6M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while HCAT trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas HCAT's P/E ratio is 10.80. In terms of profitability, SHLT's ROE is -0.50%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, SHLT is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check HCAT's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SHLT's ROE is -0.50%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SHLT is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CPSI's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, OPRX has a market cap of 125M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while OPRX trades at $6.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas OPRX's P/E ratio is 6.11. In terms of profitability, SHLT's ROE is -0.50%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, SHLT is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check OPRX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SHLT's ROE is -0.50%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SHLT is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check AUGX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CCLD has a market cap of 94.8M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CCLD trades at $2.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CCLD's P/E ratio is 8.26. In terms of profitability, SHLT's ROE is -0.50%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SHLT is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CCLD's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, DH has a market cap of 76.5M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while DH trades at $0.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas DH's P/E ratio is 2.79. In terms of profitability, SHLT's ROE is -0.50%, compared to DH's ROE of -0.67%. Regarding short-term risk, SHLT is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check DH's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas FORA's P/E ratio is -24.11. In terms of profitability, SHLT's ROE is -0.50%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SHLT is similarly volatile compared to FORA. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check FORA's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SHLT is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CCLDP's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ONMD has a market cap of 37.2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ONMD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ONMD's P/E ratio is -4.36. In terms of profitability, SHLT's ROE is -0.50%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SHLT is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check ONMD's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SHLT's ROE is -0.50%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SHLT is less volatile compared to SNCE. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SNCE's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SHLT's ROE is -0.50%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SHLT is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check AKLI's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ONMDW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SHLT is similarly volatile compared to ONMDW. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check ONMDW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SHLT's ROE is -0.50%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SHLT is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SHCRW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, EUDA has a market cap of 26.8M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while EUDA trades at $15.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas EUDA's P/E ratio is -27.08. In terms of profitability, SHLT's ROE is -0.50%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, SHLT is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check EUDA's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas STRM's P/E ratio is -2.40. In terms of profitability, SHLT's ROE is -0.50%, compared to STRM's ROE of -0.32%. Regarding short-term risk, SHLT is similarly volatile compared to STRM. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check STRM's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SHLT's ROE is -0.50%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SHLT is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check RNLX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SHLT's ROE is -0.50%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, SHLT is similarly volatile compared to LIFW. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check LIFW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, BEATW has a market cap of 18M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while BEATW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas BEATW's P/E ratio is -0.05. In terms of profitability, SHLT's ROE is -0.50%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SHLT is similarly volatile compared to BEATW. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check BEATW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SHLT's ROE is -0.50%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SHLT is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check BBLN's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SHLT's ROE is -0.50%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SHLT is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check ETAO's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while BFRG trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas BFRG's P/E ratio is -1.19. In terms of profitability, SHLT's ROE is -0.50%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SHLT is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check BFRG's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while SCNX trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas SCNX's P/E ratio is -0.15. In terms of profitability, SHLT's ROE is -0.50%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SHLT is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check SCNX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas UPH's P/E ratio is -0.07. In terms of profitability, SHLT's ROE is -0.50%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SHLT is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check UPH's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SHLT is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check UPH-WT's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, MGRX has a market cap of 4.8M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while MGRX trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas MGRX's P/E ratio is -0.35. In terms of profitability, SHLT's ROE is -0.50%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SHLT is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check MGRX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SHLT's ROE is -0.50%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SHLT is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check PEAR's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SHLT's ROE is -0.50%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SHLT is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check PEARW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SHLT's ROE is -0.50%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SHLT is similarly volatile compared to OTRK. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check OTRK's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while HCTI trades at $1.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas HCTI's P/E ratio is -0.22. In terms of profitability, SHLT's ROE is -0.50%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SHLT is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check HCTI's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SHLT's ROE is -0.50%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SHLT is similarly volatile compared to CMAX. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check CMAX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while VSEE trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas VSEE's P/E ratio is -0.17. In terms of profitability, SHLT's ROE is -0.50%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SHLT is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check VSEE's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ACON trades at $2.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ACON's P/E ratio is -0.24. In terms of profitability, SHLT's ROE is -0.50%, compared to ACON's ROE of -0.54%. Regarding short-term risk, SHLT is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check ACON's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, SHLT is similarly volatile compared to LIFWZ. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check LIFWZ's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, VSEEW has a market cap of 1.2M. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SHLT's ROE is -0.50%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SHLT is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check VSEEW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while EUDAW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, SHLT's ROE is -0.50%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, SHLT is similarly volatile compared to EUDAW. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check EUDAW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, WORX has a market cap of 602.8K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while WORX trades at $0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas WORX's P/E ratio is -0.66. In terms of profitability, SHLT's ROE is -0.50%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SHLT is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check WORX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, SHLT is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check MSPRZ's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas KERN's P/E ratio is -0.01. In terms of profitability, SHLT's ROE is -0.50%, compared to KERN's ROE of -0.17%. Regarding short-term risk, SHLT is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check KERN's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SHLT's ROE is -0.50%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, SHLT is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check KERNW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, SHLT is similarly volatile compared to LIFWW. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check LIFWW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ZCMD has a market cap of 51.1K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ZCMD trades at $1.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, SHLT's ROE is -0.50%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SHLT is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check ZCMD's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SHLT is similarly volatile compared to CMAXW. This indicates similar risk in terms of short-term price fluctuations for SHLT.Check CMAXW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, ACONW has a market cap of 11.2K. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while ACONW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas ACONW's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, SHLT is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check ACONW's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SHLT is less volatile compared to MTBCO. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check MTBCO's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas AFFX's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SHLT is less volatile compared to AFFX. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check AFFX's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, SHLT is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check MTBCP's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas MTBC's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, SHLT is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check MTBC's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SHLT's ROE is -0.50%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SHLT is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CHNG's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SHLT is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CHNGU's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, HLTH has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while HLTH trades at $25.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas HLTH's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, SHLT is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check HLTH's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SHLT's ROE is -0.50%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SHLT is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CNVY's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas NAVA's P/E ratio is N/A. In terms of profitability, SHLT's ROE is -0.50%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, SHLT is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for SHLT.Check NAVA's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CERN has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CERN's P/E ratio is 55.84. In terms of profitability, SHLT's ROE is -0.50%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SHLT is less volatile compared to CERN. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CERN's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SHLT's ROE is -0.50%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SHLT is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check CSLT's competition here

SHL Telemedicine Ltd. (NASDAQ: SHLT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SHLT stands at 33.6M. In comparison, NH has a market cap of 0. Regarding current trading prices, SHLT is priced at $2.05 on the NASDAQ, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SHLT currently has a P/E ratio of -3.87, whereas NH's P/E ratio is -0.12. In terms of profitability, SHLT's ROE is -0.50%, compared to NH's ROE of +0.35%. Regarding short-term risk, SHLT is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for SHLT.Check NH's competition here